The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Naringenin as a potential immunomodulator in therapeutics
Abstract
Naringenin, a citrus flavonoid that possesses various biological activities, has emerged as a potential therapeutic agent for the management of a variety of diseases. Studies using cell culture system have shown that naringenin can inhibit inflammatory response in diverse cell types. Moreover, research using various animal models has further demonstrated therapeutic potentials of naringenin in the treatment of several inflammation-related disorders, such as sepsis, fulminant hepatitis, fibrosis and cancer. The mechanism of action of naringenin is not completely understood but recent mechanistic studies revealed that naringenin suppresses inflammatory cytokine production through both transcriptional and post-transcriptional mechanisms. Surprisingly, naringenin not only inhibits cytokine mRNA expression but also promotes lysosome-dependent cytokine protein degradation. This unique property of naringenin stands in sharp contrast with some widely-studied natural products such as apigenin and curcumin, which regulate cytokine production essentially at the transcriptional level. Therefore, naringenin may provide modality for the development of novel anti-inflammatory agent. This review article summarizes our recent studies in understanding how naringenin acts in cells and animal models. Particularly, we will discuss the anti-inflammatory activities of naringenin in various disease context and its potential use, as an immunomodulator, in the treatment of inflammatory related disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H., & Benjamin, E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342603 · Cited by 1,241
Anti-TNF-α therapies: the next generation
Palladino, M. A., Bahjat, F. R., Theodorakis, E. A., & Moldawer, L. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1175 · Cited by 576
Comalada, M., Ballester, I., Bailón, E., Sierra, S., Xaus, J., Gálvez, J., Medina, F. S. D., & Zarzuelo, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.016 · Cited by 440
T cells use two directionally distinct pathways for cytokine secretion
Huse, M., Lillemeier, B. F., Kuhns, M. S., Chen, D. S., & Davis, M. M. (2006) · Nature Immunology · doi:10.1038/ni1304 · Cited by 436
Smith, A. M., Rahman, F. Z., Hayee, B., Graham, S. J., Marks, D. J. B., Sewell, G. W., Palmer, C. D., Wilde, J., Foxwell, B. M. J., Gloger, I. S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091233 · Cited by 398
A role for the phagosome in cytokine secretion
Murray, R. Z., Kay, J. G., Sangermani, D. G., & Stow, J. L. (2005) · Science · doi:10.1126/science.1120225 · Cited by 330
Selective Transcription in Response to an Inflammatory Stimulus
Smale, S. T. (2010) · Cell · doi:10.1016/j.cell.2010.01.037 · Cited by 315
Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols
Gupta, S. C., Tyagi, A. K., Deshmukh-Taskar, P., Hinojosa, M., Prasad, S., & Aggarwal, B. B. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.06.006 · Cited by 313
Mulvihill, E. E., Allister, E. M., Sutherland, B. G., Telford, D. E., Sawyez, C. G., Edwards, J. Y., Markle, J. M., Hegele, R. A., & Huff, M. W. (2009) · Diabetes · doi:10.2337/db09-0634 · Cited by 297
Cited by
Polyphenols: A concise overview on the chemistry, occurrence, and human health
Durazzo, A., Lucarini, M., Souto, E. B., Cicala, C., Caiazzo, E., Izzo, A. A., Novellino, E., & Santini, A. (2019) · Phytotherapy Research · doi:10.1002/ptr.6419 · Cited by 802
Naringenin: A potential flavonoid phytochemical for cancer therapy
Motallebi, M., Bhia, M., Rajani, H. F., Bhia, I., Tabarraei, H., Mohammadkhani, N., Pereira-Silva, M., Kasaii, M. S., Nouri-Majd, S., Mueller, A.-L., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120752 · Cited by 328
Wang, Q., Ou, Y., Hu, G., Wen, C., Yue, S., Chen, C., Xu, L., Xie, J., Dai, H., Xiao, H., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14938 · Cited by 309
Antidiabetic Properties of Naringenin: A Citrus Fruit Polyphenol
Den Hartogh, D. J., & Tsiani, E. (2019) · Biomolecules · doi:10.3390/biom9030099 · Cited by 267
The macrophage polarization in inflammatory dermatosis and its potential drug candidates
Sun, Q., Hu, S., Lou, Z., & Gao, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114469 · Cited by 66
Metadata
- Authors
- Zeng, W., Jin, L., Zhang, F., Zhang, C., & Liang, W.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 135
- Pages
- 122-126
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2887825035
- Cited by
- 305
- References
- 87
- FWCI
- 9.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Naringenin as a potential immunomodulator in therapeutics. https://app.cochat.ai/papers/10.1016/j.phrs.2018.08.002
- The paper
- Zeng, W., Jin, L., Zhang, F., Zhang, C., & Liang, W. (2018). Naringenin as a potential immunomodulator in therapeutics. Pharmacological Research. https://doi.org/10.1016/j.phrs.2018.08.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
